Dr Jonathan Jacobson
Dr Jonathan Jacobson
Dr Jonathan Jacobson is a microbiologist who completed his PhD in 2019 at the Peter Doherty Institute, at the University of Melbourne, focusing on discovering new drug candidates to target HIV-1. Jonathan joined Translational Microbiology team at the Murdoch Children’s Research Institute in 2019
Dr Jonathan Jacobson is a microbiologist who completed his PhD in 2019 at the Peter Doherty Institute, at the University of Melbourne, focusing on discovering new drug candidates to target HIV-1. Jonathan joined Translational Microbiology team at the...
Dr Jonathan Jacobson is a microbiologist who completed his PhD in 2019 at the Peter Doherty Institute, at the University of Melbourne, focusing on discovering new drug candidates to target HIV-1. Jonathan joined Translational Microbiology team at the Murdoch Children’s Research Institute in 2019
Top Publications
- Manna, S, McAuley, J, Jacobson, J, Nguyen, CD, Ullah, A, Williamson, V, Mulholland, EK, Wijburg, O, Phipps, S, Satzke, C. Synergism and antagonism of bacterial-viral co-infection in the upper respiratory tract. 2024 view publication
- Jacobson, J, Fabri, L, Shanthikumar, S, Osowicki, J, Costa, A, Daley, A, Teague, W, Buttery, J, Steer, A, Ranganathan, S, et al. Molecular method improves bacterial identification in paediatric pleural empyema. Respirology 26(S2) : 2024 view publication
- Jacobson, J, Fabri, L, Shanthikumar, S, Osowicki, J, Costa, A, Daley, A, Teague, W, Buttery, J, Ranganathan, S, Dunne, E, et al. MATE: Molecular Assessment Thoracic Empyema. Respirology 102 -102 2024 view publication
- Jacobson, J, Fabri, L, Osowicki, J, Shanthikumar, S, Costa, A-M, Ortika, B, Wee-Hee, A, Pragassen, M, Gatt, C, Gonis, G, et al. Evaluation of a multiplex-qPCR for paediatric pleural empyema-An observational study in hospitalised children.. PLoS One 19(6) : e0304861 2024 view publication
- Abrehart, T, Suryadinata, R, McCafferty, C, Jacobson, J, Ignjatovic, V, Robinson, P, Crawford, NW, Monagle, P, Subbarao, K, Satzke, C, et al. Age-related differences in SARS-CoV-2 binding factors: An explanation for reduced susceptibility to severe COVID-19 among children?. Paediatr Respir Rev 44: 61 -69 2022 view publication
Page 1 of 3
Career information
Share //
